Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
41 hedge funds and large institutions have $30.6M invested in Alexza Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 2 closing their positions.
835% more call options, than puts
Call options by funds: $6.77M | Put options by funds: $724K
600% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
48% more capital invested
Capital invested by funds: $20.7M → $30.6M (+$9.87M)
37% more funds holding
Funds holding: 30 → 41 (+11)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.91M |
| 2 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
+$684K |
| 3 |
LPA
Lansdowne Partners Austria
Vienna,
Austria
|
+$671K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$657K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$656K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPLP
Lansdowne Partners Limited Partnership
London,
United Kingdom
|
-$1.33M |
| 2 |
BCM
BBT Capital Management
Fort Worth,
Texas
|
-$68.2K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$62.1K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$14.1K |
| 5 |
Goldman Sachs
New York
|
-$11.3K |
ALXA Hedge Fund Activity: Q3 2013 in Review
41 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q3 2013, worth a combined $30.6M — up 48% from $20.7M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ALXA positions and 2 closed out — a net gain of 12 holders — while 12 added to existing stakes and 6 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.91M. The largest seller was Lansdowne Partners Limited Partnership, exiting entirely with an estimated $1.33M sold.
- 41 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q3 2013, up from 30 in Q2 2013.
- Funds reported $30.6M of Alexza Pharmaceuticals Inc stock for Q3 2013, up 48% quarter-over-quarter.
- 14 funds opened new Alexza Pharmaceuticals Inc positions in Q3 2013 and 2 closed out, a net change of +12 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q3 2013 was Morgan Stanley, an estimated $1.91M added.
- The largest Alexza Pharmaceuticals Inc seller in Q3 2013 was Lansdowne Partners Limited Partnership, an estimated $1.33M sold.
Based on aggregated 13F filings for Q3 2013.